Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)

Kodiak Sciences (KOD) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $306.0 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 2.72% year-over-year to $306.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 19.56% YoY) and the FY2025 annual result came in at $351.5 million, up 4.75% from the prior year.
• Liabilities and Shareholders Equity declined to $306.0 million in Q1 2026, from $351.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $850.3 million in Q1 2022 to a low of $218.1 million in Q3 2025.
• A 5-year average of $485.6 million and a median of $434.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 4.75% in 2025, down 41.48% in 2025.
• Tracing KOD's Liabilities and Shareholders Equity over 5 years: stood at $666.6 million in 2022, then retreated by 28.09% to $479.4 million in 2023, then decreased by 30.0% to $335.6 million in 2024, then advanced by 4.75% to $351.5 million in 2025, then dropped by 12.95% to $306.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $306.0 million (Q1 2026), $351.5 million (Q4 2025), and $218.1 million (Q3 2025), per Business Quant data.